Global Plasmapheresis Device Market Growth 2026-2032
Description
The global Plasmapheresis Device market size is predicted to grow from US$ 478 million in 2025 to US$ 637 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.
In 2025, global Plasmapheresis Device production reached approximately 18,060 units, with an average global market price of around US$ 27,057 per unit.
A Plasmapheresis Device is a medical device used in plasmapheresis, a procedure that involves the removal, treatment, and return of plasma from a patient's blood. Plasma is the pale-yellow liquid component of blood that contains water, electrolytes, proteins, and waste products. During plasmapheresis, blood is drawn from the patient’s body, the plasma is separated, and the remaining blood components, such as red blood cells, white blood cells, and platelets, are returned to the body. The removed plasma may be discarded, replaced with donor plasma, or treated with specific substances, depending on the medical condition being addressed.
Plasmapheresis Devices are extracorporeal circulation devices used to collect and/or therapeutically separate blood components. Using centrifugal separation or membrane-based separation within a single-use closed-loop disposable set, they separate whole blood into plasma and cellular components, returning red cells (and other specified components) to the donor/patient in a controlled ratio. Their core value proposition is safe, controllable, and fully traceable separation and reinfusion, improving collection efficiency while reducing operator burden. Typical systems integrate pump/valve and sensor control, a centrifuge rotor or filtration module, precise anticoagulant infusion, pressure/air monitoring, weighing/volume measurement, interlocked alarms, and barcode/e-record interfaces—serving source-plasma collection centers, therapeutic plasma exchange (TPE), and cellular apheresis in hospitals.
Production model: commonly delivered as a bundled model of installed equipment + recurring single-use disposables (tubing/sets) + software upgrades + service/maintenance. OEMs typically combine outsourced modules (motors, sensors, control boards, etc.) with in-house system integration; disposables emphasize medical-grade polymers, precision extrusion/injection molding, sterilization, and validation, while software emphasizes algorithms, data logging, and compliance-ready audit trails.
Gross margin (indicative range): recurring disposables and service typically lift blended margins above ordinary durable equipment; public disclosures from leading players show ~40%–50% gross margin (varying by period and metric), a practical benchmark for the segment.
Value chain: upstream includes medical-grade polymers (disposables), stainless steel/precision parts, pumps/valves/motors/sensors, controls & software; midstream includes system assembly/calibration, disposables molding & sterilization, software verification/system testing, registration & quality systems; downstream includes source-plasma centers/blood establishments and hospital departments performing TPE and cellular apheresis.
Market Development Opportunities & Main Driving Factors
Demand is jointly driven by expanding plasma supply capacity and growing demand for plasma-derived therapies.
Market Challenges, Risks, & Restraints
This is a near-zero-tolerance compliance-and-safety market. In 2024, FDA issued/updated guidance on informed consent and donor-eligibility determination, increasing the “must-have” spend on procedures, data traceability, and quality systems; in China, source-plasma stations are planned and approved under strict rules and are set up by plasma product manufacturers, keeping expansion disciplined. On top of this, sterilized consumables, critical components, and software/cybersecurity supply risks—and EU conformity assessment / notified-body requirements—can lengthen time-to-market and increase cost.
Downstream Demand Trends
Downstream is bifurcating: collection centers prioritize yield per session, throughput, and operational digitization; hospitals performing TPE/cellular apheresis prioritize clinical safety and traceability. Going forward, individualized collection algorithms, integration with donor management systems, and subscription-like procurement of “equipment + single-use disposables + service” will be central levers for customer stickiness and margin structure optimization.
The global major manufacturers of Plasmapheresis Devices include Terumo BCT, Fresenius Kabi, Haemonetics, Baxter, B. Braun, Nikkiso, Miltenyi Biotec, Asahi Kasei Medical, Kaneka Medix, Nigale, Haier Biomedical, Scinomed, Medica SPA, Dahua Medical Instrument, etc. In terms of revenue, the global three largest players hold a 67% market share of Plasmapheresis Devices in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Plasmapheresis Device Industry Forecast” looks at past sales and reviews total world Plasmapheresis Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Plasmapheresis Device sales for 2026 through 2032. With Plasmapheresis Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasmapheresis Device industry.
This Insight Report provides a comprehensive analysis of the global Plasmapheresis Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plasmapheresis Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plasmapheresis Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasmapheresis Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasmapheresis Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasmapheresis Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Desktop Type
Trolley Type
Segmentation by Technology:
Centrifugal Separation
Membrane Separation
Segmentation by End Users:
Hospitals
Blood Centers
Others
Segmentation by Application:
Extracorporeal Therapy
Plasma Donation
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Terumo BCT
Fresenius Kabi
Haemonetics
Baxter
B. Braun
Nikkiso
Miltenyi Biotec
Asahi Kasei Medical
Kaneka Medix
Nigale
Haier Biomedical
Scinomed
Medica SPA
Dahua Medical Instrument
Key Questions Addressed in this Report
What is the 10-year outlook for the global Plasmapheresis Device market?
What factors are driving Plasmapheresis Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasmapheresis Device market opportunities vary by end market size?
How does Plasmapheresis Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
In 2025, global Plasmapheresis Device production reached approximately 18,060 units, with an average global market price of around US$ 27,057 per unit.
A Plasmapheresis Device is a medical device used in plasmapheresis, a procedure that involves the removal, treatment, and return of plasma from a patient's blood. Plasma is the pale-yellow liquid component of blood that contains water, electrolytes, proteins, and waste products. During plasmapheresis, blood is drawn from the patient’s body, the plasma is separated, and the remaining blood components, such as red blood cells, white blood cells, and platelets, are returned to the body. The removed plasma may be discarded, replaced with donor plasma, or treated with specific substances, depending on the medical condition being addressed.
Plasmapheresis Devices are extracorporeal circulation devices used to collect and/or therapeutically separate blood components. Using centrifugal separation or membrane-based separation within a single-use closed-loop disposable set, they separate whole blood into plasma and cellular components, returning red cells (and other specified components) to the donor/patient in a controlled ratio. Their core value proposition is safe, controllable, and fully traceable separation and reinfusion, improving collection efficiency while reducing operator burden. Typical systems integrate pump/valve and sensor control, a centrifuge rotor or filtration module, precise anticoagulant infusion, pressure/air monitoring, weighing/volume measurement, interlocked alarms, and barcode/e-record interfaces—serving source-plasma collection centers, therapeutic plasma exchange (TPE), and cellular apheresis in hospitals.
Production model: commonly delivered as a bundled model of installed equipment + recurring single-use disposables (tubing/sets) + software upgrades + service/maintenance. OEMs typically combine outsourced modules (motors, sensors, control boards, etc.) with in-house system integration; disposables emphasize medical-grade polymers, precision extrusion/injection molding, sterilization, and validation, while software emphasizes algorithms, data logging, and compliance-ready audit trails.
Gross margin (indicative range): recurring disposables and service typically lift blended margins above ordinary durable equipment; public disclosures from leading players show ~40%–50% gross margin (varying by period and metric), a practical benchmark for the segment.
Value chain: upstream includes medical-grade polymers (disposables), stainless steel/precision parts, pumps/valves/motors/sensors, controls & software; midstream includes system assembly/calibration, disposables molding & sterilization, software verification/system testing, registration & quality systems; downstream includes source-plasma centers/blood establishments and hospital departments performing TPE and cellular apheresis.
Market Development Opportunities & Main Driving Factors
Demand is jointly driven by expanding plasma supply capacity and growing demand for plasma-derived therapies.
Market Challenges, Risks, & Restraints
This is a near-zero-tolerance compliance-and-safety market. In 2024, FDA issued/updated guidance on informed consent and donor-eligibility determination, increasing the “must-have” spend on procedures, data traceability, and quality systems; in China, source-plasma stations are planned and approved under strict rules and are set up by plasma product manufacturers, keeping expansion disciplined. On top of this, sterilized consumables, critical components, and software/cybersecurity supply risks—and EU conformity assessment / notified-body requirements—can lengthen time-to-market and increase cost.
Downstream Demand Trends
Downstream is bifurcating: collection centers prioritize yield per session, throughput, and operational digitization; hospitals performing TPE/cellular apheresis prioritize clinical safety and traceability. Going forward, individualized collection algorithms, integration with donor management systems, and subscription-like procurement of “equipment + single-use disposables + service” will be central levers for customer stickiness and margin structure optimization.
The global major manufacturers of Plasmapheresis Devices include Terumo BCT, Fresenius Kabi, Haemonetics, Baxter, B. Braun, Nikkiso, Miltenyi Biotec, Asahi Kasei Medical, Kaneka Medix, Nigale, Haier Biomedical, Scinomed, Medica SPA, Dahua Medical Instrument, etc. In terms of revenue, the global three largest players hold a 67% market share of Plasmapheresis Devices in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Plasmapheresis Device Industry Forecast” looks at past sales and reviews total world Plasmapheresis Device sales in 2025, providing a comprehensive analysis by region and market sector of projected Plasmapheresis Device sales for 2026 through 2032. With Plasmapheresis Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasmapheresis Device industry.
This Insight Report provides a comprehensive analysis of the global Plasmapheresis Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plasmapheresis Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Plasmapheresis Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasmapheresis Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasmapheresis Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasmapheresis Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Desktop Type
Trolley Type
Segmentation by Technology:
Centrifugal Separation
Membrane Separation
Segmentation by End Users:
Hospitals
Blood Centers
Others
Segmentation by Application:
Extracorporeal Therapy
Plasma Donation
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Terumo BCT
Fresenius Kabi
Haemonetics
Baxter
B. Braun
Nikkiso
Miltenyi Biotec
Asahi Kasei Medical
Kaneka Medix
Nigale
Haier Biomedical
Scinomed
Medica SPA
Dahua Medical Instrument
Key Questions Addressed in this Report
What is the 10-year outlook for the global Plasmapheresis Device market?
What factors are driving Plasmapheresis Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasmapheresis Device market opportunities vary by end market size?
How does Plasmapheresis Device break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
112 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Plasmapheresis Device by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Plasmapheresis Device by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
